A new oral drug called AC01 was found safe and well tolerated in a 58-patient early trial for chronic heart failure.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
New oral heart failure drug appears to be safe and well tolerated in 58-patient early clinical trial
AC01 (Ghrelin Receptor Agonist) Drug tested
58 Patients Trial participants
Phase Ib/2a Trial phase
None Serious Side effects
Karolinska Institutet, Sweden Study location
Ib/2a trial phase
58 patients tested